Products
Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.
All Products (882)
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Mitotane |
Enzyme / Oncolytic Virus / Miscellaneous Cytotoxic | Both (Solid & Hematologic) | ||
|
Molecule
Mitotane
Therapeutic Category
Cytotoxic Chemotherapy / Miscellaneous
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Enzyme / Oncolytic Virus / Miscellaneous Cytotoxic |
||||
Mitoxantrone |
Anthracycline / Anthracenedione | Both (Solid & Hematologic) | ||
|
Molecule
Mitoxantrone
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
||||
Morphine Sulfate |
Opioid / Adjuvant Analgesic | Both (Solid & Hematologic) | ||
|
Molecule
Morphine Sulfate
Therapeutic Category
Supportive Care (Analgesic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Opioid / Adjuvant Analgesic |
||||
Nabilone |
Appetite Stimulant / Anabolic Agent | Both (Solid & Hematologic) | ||
|
Molecule
Nabilone
Therapeutic Category
Supportive Care (Nutrition/Cachexia)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Appetite Stimulant / Anabolic Agent |
||||
Nadroparin Calcium |
Anticoagulant (Cancer-Associated Thrombosis) | Both (Solid & Hematologic) | ||
|
Molecule
Nadroparin Calcium
Therapeutic Category
Supportive Care (Anticoagulant)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anticoagulant (Cancer-Associated Thrombosis) |
||||
Namitecan |
Topoisomerase Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Namitecan
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
||||
Nedaplatin |
Platinum Compound | Solid Tumour | ||
|
Molecule
Nedaplatin
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
Platinum Compound |
||||
Nelarabine |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Nelarabine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Netupitant |
NK-1 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Netupitant
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
||||
Netupitant-Palonosetron Combo |
NK-1 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Netupitant-Palonosetron Combo
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
||||
Nilutamide |
Antiandrogen | Solid Tumour (Prostate) | ||
|
Molecule
Nilutamide
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
Antiandrogen |
||||
Nimustine |
Alkylating Agent | Both (Solid & Hematologic) | ||
|
Molecule
Nimustine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
||||
MitotaneCytotoxic Chemotherapy / Miscellaneous |
|
|
Therapeutic Category
Cytotoxic Chemotherapy / Miscellaneous
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Enzyme / Oncolytic Virus / Miscellaneous Cytotoxic |
|
MitoxantroneCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
|
Morphine SulfateSupportive Care (Analgesic) |
|
|
Therapeutic Category
Supportive Care (Analgesic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Opioid / Adjuvant Analgesic |
|
NabiloneSupportive Care (Nutrition/Cachexia) |
|
|
Therapeutic Category
Supportive Care (Nutrition/Cachexia)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Appetite Stimulant / Anabolic Agent |
|
Nadroparin CalciumSupportive Care (Anticoagulant) |
|
|
Therapeutic Category
Supportive Care (Anticoagulant)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anticoagulant (Cancer-Associated Thrombosis) |
|
NamitecanCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
|
NedaplatinCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
Platinum Compound |
|
NelarabineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
NetupitantSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
|
Netupitant-Palonosetron ComboSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
|
NilutamideHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
Antiandrogen |
|
NimustineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
|